Label Image (Lbl500907170)
Lurasidone Hydrochloride Tablet, Film Coated
Product Images NDC 50090-7170
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lurasidone Hydrochloride (NDC 50090-7170). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Lurasidone-structure (Lurasidone 1)
Lurasidone-fig2 (Lurasidone Fig2)
This information is evaluating the impact of other drugs on the pharmacokinetics of Lurasidone. It includes data on drug interaction, fold change, and confidence interval percentages for different drugs such as a strong CYP3A5 inhibitor (Ketoconazole) and strong CYP3A5 inducers (Rifampin, St. John's Wort, and Carbamazepine).*
Lurasidone-fig2 (Lurasidone Fig3)
This is a description of a study on an interacting drug, showing the change in Pap Substrates when combined with different medications like Digoin and Mdazoam. The text mentions Fold Change and 90% confidence intervals in relation to drug interactions.*
Lurasidone-fig3 (Lurasidone Fig4)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
